Results 141 to 150 of about 16,181 (154)

Pharmacodynamic Comparison of Ticagrelor Monotherapy Versus Ticagrelor and Aspirin in Patients After Percutaneous Coronary Intervention: The TEMPLATE (Ticagrelor Monotherapy and Platelet Reactivity) Randomized Controlled Trial

Journal of the American Heart Association, 2020
Andrew Mumford, Thomas W Johnson
exaly  

Characterization of the Adenosine Pharmacology of Ticagrelor Reveals Therapeutically Relevant Inhibition of Equilibrative Nucleoside Transporter 1

Journal of Cardiovascular Pharmacology and Therapeutics, 2014
J J J van Giezen, James E Sidaway
exaly  

Premature Ticagrelor Discontinuation in Secondary Prevention of Atherosclerotic CVD

Journal of the American College of Cardiology, 2019
Kamal Shemisa, Sameer Arora, Sandeep R Das   +2 more
exaly  

Ticagrelor

The Nurse Practitioner, 2012
openaire   +1 more source

Adenosine-mediated effects of ticagrelor: evidence and potential clinical relevance.

Journal of the American College of Cardiology, 2014
Rainer Schulz, Marco Cattaneo, Sven Nylander   +2 more
exaly  

Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans

Journal of the American College of Cardiology, 2013
Ann Wittfeldt, Li-Ming Gan, Sven Nylander   +2 more
exaly  

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Lancet, The, 2018
Norihiro Kogame, Florian Krackhardt
exaly  

Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction

Circulation, 2016
Marc S Sabatine
exaly  

Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial.

Journal of the American College of Cardiology, 2011
Joseph Ycas, Claes Held, Robert F. Storey   +2 more
exaly  

Pharmacodynamics, pharmacokinetics and safety of ticagrelor in Asian patients with stable coronary artery disease

Cardiovascular Intervention and Therapeutics, 2014
R Teng
exaly